Pharmacovigilance study of adverse events of vedolizumab based on the FAERS database
Abstract This study aims to assess the adverse event profile of vedolizumab (Entyvio®) using FDA Adverse Event Reporting System (FAERS) data to identify potential safety risks and support clinical use. FAERS data from Q1 2014 to Q1 2024 were analyzed. Adverse drug events (ADEs) related to vedolizuma...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Nature Portfolio
2025-10-01
|
| Sarja: | Scientific Reports |
| Aiheet: | |
| Linkit: | https://doi.org/10.1038/s41598-025-21609-y |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|